1Hofbauer,Lorenz C,Heufelder,et al.The role of receptor activator of nuclear factor-[kappa]B ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone disease[J].Clin Endocrinol Metab,2000,85(7):2355
2Announcements.Endocrinology nomenclature on RANK,RANKL and OPG[J].Endocrinology,2001,142(1):88
4Saika Mieko,Inoue Daisuke,Kido Shinsuke,et al.17 [beta]-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line,ST-2,via estrogen receptor-[alpha][J].Endocrinology,2001,142(6):2205
5Kong YY,Yoshida H,Sarosi I,et al.OPGL is a key regulator osteoclastogenesis,lymphocyte development and lymph-node organogenesis[J].Nature,1999,397:315
6Hsu H,Lacey DL,Dunstan CR,et al.Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand[J].Proc Natl Acad Sci USA,1999,96:3540
7Li J,Sarosi I,Yan XQ,et al.RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism[J].Proc Natl Acad Sci USA,2000,97:1566
8Bord S,Ireland DC,Beavan SR,et al.The effects of estrogen on osteoprotegerin,RANKL,and estrogen receptor expression in human osteoblasts[J].Bone,2003,32:136
10Yano K,Tsuda E,Washida N,et al.Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor:increased serum concentrations in postmenopausal women with osteoporosis[J].J Bone Miner Res,1999,14:518
二级参考文献7
1[1]Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density.Cell,1997,89:309-319.
2[2]Toesca A,Pagnotta A,Specchia N.Evidence of type Ⅱ estrogen receptor in human osteoblast-like cells.Cell Biol Int,2000,24:303-309.
4[4]Bucay N,Sarosi I,Dunstan CR,et al.Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.Genes Dev,1998,12:1260-1268.
5[5]Hofbauer LC,Dunstan CR,Spelsberg TC,et al.Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D,bone morphogenetic protein-2,and cytokines.Biochem Biophys Res Commun,1998,250:776-781.
6[6]Howell A,Osborne CK,Morris C,et al.ICI182780(FaslodexTM),development of a novel,"pure"antiestrogen.Cancer,2000,89:817-825.
7[7]Sibonga JD,Dobnig H,Harden RM,et al.Effect of the high-affinity estrogen receptor ligand ICI182780 on the rat tibia.Endocrinology,1998,139:3736-3742.
